Business

OXB to Present at the 28th Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT)

OXB to Present at the 28th Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT) Oxford, UK – 9 May 2025: OXB (LSE: OXB), a global quality and innovation-led cell and gene therapy CDMO, today announces its participation in the 28th Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT), taking place from 13–17 May 2025 at the Ernest N. Morial Convention Center in New Orleans, Louisiana. The Company will exhibit at Booth #1611, where delegates can meet OXB’s tea

articleOxford Biomedica PlcMay 9, 20253/company/oxford-biomedica-plc/news/oxb-to-present-at-the-28th-annual-meeting-of-the-american-society-of-gene-and-cell-therapy-asgct
OXB to Present at the 28th Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT)

About this update from Oxford Biomedica Plc

[{"type":"image","alt":"OXB","displaySize":"","headline":null,"caption":"OXB","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":159,"url":"https://media.zenfs.com/en/globenewswire.com/c14d9d68668513a9042681f5e1f388c2"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/fa8vdAQ1u36jC9pq9QpcgQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTIyMztjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/c14d9d68668513a9042681f5e1f388c2","width":300,"height":159}},"lazy":false},{"type":"text","content":"OXB to Present at the 28th Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT)","length":98,"tagName":"p","attribs":{}},{"type":"text","content":"Oxford, UK – 9 May 2025: OXB (LSE: OXB), a global quality and innovation-led cell and gene therapy CDMO, today announces its participation in the 28th Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT), taking place from 13–17 May 2025 at the Ernest N. Morial Convention Center in New Orleans, Louisiana.","length":330,"tagName":"p"},{"type":"text","content":"The Company will exhibit at Booth #1611, where delegates can meet OXB’s team of viral vector experts and explore its development and manufacturing capabilities across lentiviral, AAV and other viral vector types.","length":212,"tagName":"p"},{"type":"text","content":"OXB will also contribute to the scientific programme through an industry-sponsored symposium, five poster presentations, and two oral presentations.","length":148,"tagName":"p"},{"type":"text","content":"Industry-Sponsored Symposium","length":28,"tagName":"p"},{"type":"text","content":"Accelerate Time to Clinic: A Process and Analytics Platform Approach","length":68,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Speaker: Ify Iwuchukwu, PhD, Vice President, Development Services, Head of Process and Analytical Development","length":109,"tagName":"p"}]},{"val":[{"type":"text","content":"Date: Tuesday, 13 May 2025","length":26,"tagName":"p"}]},{"val":[{"type":"text","content":"Time: 14:00–14:30 CDT","length":21,"tagName":"p"}]},{"val":[{"type":"text","content":"Location: Room 391–392","length":22,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":178,"olType":false},{"type":"text","content":"Poster Presentations","length":20,"tagName":"p"},{"type":"text","content":"The 3 Rs of Replication-Competent Lenti...

More updates from Oxford Biomedica Plc

OXBviral vectorgene therapyCell Therapyglobal qualityLocation